Physician profile
Amanda Liesner
NPI 1861158529
$1,628.51
in general payments reported to CMS, 2019-2025
17 companies · $642 in 2025
The $642 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $986 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,575 · Education: $54.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,574.51 |
| Education | $54.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $254.52 | 2024-2025 | Ultomiris |
| E.R. Squibb & Sons, L.L.C. | $244.70 | 2024-2025 | Zeposia |
| Abbvie INC. | $242.64 | 2024-2025 | |
| Emd Serono, INC. | $230.00 | 2024-2025 | Mavenclad |
| Teva Pharmaceuticals USA, INC. | $120.35 | 2025 | Austedo Xr |
| Harmony Biosciences LLC | $118.16 | 2024-2025 | |
| Livanova USA, INC. | $97.18 | 2024-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Tg Therapeutics, INC. | $55.67 | 2024-2025 | |
| Medtronic, INC. | $54.00 | 2024 | Percept PC Brainsense |
| Impel Pharmaceuticals LLC | $47.82 | 2025 | Trudhesa |
| Lilly USA, LLC | $30.91 | 2024-2025 | Emgality, Kisunla |
| Ucb, INC. | $24.02 | 2025 | Zilbrysq |
| Sk Life Science, INC. | $23.82 | 2024 | |
| Celgene Corporation | $22.67 | 2025 | Zeposia |
| Janssen Biotech, INC. | $22.56 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $22.27 | 2024 | Rytary |
| Novartis Pharmaceuticals Corporation | $17.22 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Liesner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.